Eculizumab in a patient with dense-deposit disease.

This letter indicates that in a patient with long-standing dense-deposit disease, a variant of membranoproliferative glomerulonephritis, eculizumab can be useful in the resolution of the nephrotic ...

[1]  M. Pickering,et al.  Dense deposit disease. , 2011, Molecular immunology.

[2]  M. Gordon.  The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria , 2008 .

[3]  John D Lambris,et al.  New approaches to the treatment of dense deposit disease. , 2007, Journal of the American Society of Nephrology : JASN.

[4]  M. Walport,et al.  Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  John D Lambris,et al.  Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. , 2005, Journal of the American Society of Nephrology : JASN.